deltatrials
Unknown PHASE3 NCT00000158

Macular Photocoagulation Study (MPS)

Sponsor: National Eye Institute (NEI)

Conditions Choroidal Neovascularization Histoplasmosis Macular Degeneration
Interventions Argon Blue-Green Laser Photocoagulation
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Feb 28, 1979

Listed as NCT00000158, this PHASE3 trial focuses on Choroidal Neovascularization and Histoplasmosis and remains ongoing. Sponsored by National Eye Institute (NEI), it has been updated 5 times since 1979, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Feb 1979

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Eye Institute (NEI)
Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.